230 related articles for article (PubMed ID: 38291285)
21. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
Tsiogka A; Gregoriou S; Stratigos A; Soulaidopoulos S; Rompoti N; Panagakis P; Papoutsaki M; Kostakis P; Kontochristopoulos G; Tsioufis K; Campanati A; Offidani A; Vlachopoulos C; Rigopoulos D
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830855
[TBL] [Abstract][Full Text] [Related]
23. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
[TBL] [Abstract][Full Text] [Related]
24. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
[TBL] [Abstract][Full Text] [Related]
25. Selected miRNA and Psoriasis-Cardiovascular Disease (CVD)-Overweight/Obesity Network-A Pilot Study.
Michalak-Stoma A; Walczak K; Adamczyk M; Kowal M; Krasowska D
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762217
[TBL] [Abstract][Full Text] [Related]
26. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome.
Trovato E; Rubegni P; Prignano F
Expert Opin Biol Ther; 2022 Dec; 22(12):1443-1448. PubMed ID: 35726639
[TBL] [Abstract][Full Text] [Related]
27. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
28. Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.
Ntusi NAB; Francis JM; Sever E; Liu A; Piechnik SK; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
Int J Cardiol; 2018 Nov; 270():253-259. PubMed ID: 30017519
[TBL] [Abstract][Full Text] [Related]
29. Oxidized Lipids and Lipoprotein Dysfunction in Psoriasis.
Sorokin AV; Remaley AT; Mehta NN
J Psoriasis Psoriatic Arthritis; 2020 Oct; 5(4):139-146. PubMed ID: 33163854
[TBL] [Abstract][Full Text] [Related]
30. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
Sunbul M; Agirbasli M
Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease in psoriatic post-menopausal women.
Pietrzak A; Czuczwar P; Mosiewicz J; Paszkowski T; Chodorowska G; Bartosinska J; Gerkowicz A; Paluszkiewicz P; Freud T; Cohen AD
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1231-4. PubMed ID: 25073722
[TBL] [Abstract][Full Text] [Related]
32. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.
Fernández-Gutiérrez B; Perrotti PP; Gisbert JP; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; García-Sánchez V; Panés J; Fonseca E; Blanco F; Rodríguez-Moreno J; Carreira P; Julià A; Marsal S; Rodriguez-Rodriguez L;
Medicine (Baltimore); 2017 Jun; 96(26):e7308. PubMed ID: 28658137
[TBL] [Abstract][Full Text] [Related]
34. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
Goyal A; Dey AK; Chaturvedi A; Elnabawi YA; Aberra TM; Chung JH; Belur AD; Groenendyk JW; Lerman JB; Rivers JP; Rodante JA; Harrington CL; Varghese NJ; Sanda GE; Baumer Y; Sorokin AV; Teague HL; Genovese LD; Natarajan B; Joshi AA; Playford MP; Bluemke DA; Chen MY; Alavi A; Pitman RK; Powell-Wiley TM; Tawakol A; Gelfand JM; Mehta NN
JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):465-477. PubMed ID: 30448131
[TBL] [Abstract][Full Text] [Related]
35. Ischemic cardiovascular involvement in psoriasis: a systematic review.
Mosca S; Gargiulo P; Balato N; Di Costanzo L; Parente A; Paolillo S; Ayala F; Trimarco B; Crea F; Perrone-Filardi P
Int J Cardiol; 2015 Jan; 178():191-9. PubMed ID: 25464252
[TBL] [Abstract][Full Text] [Related]
36. Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.
Lee MP; Desai RJ; Jin Y; Brill G; Ogdie A; Kim SC
JAMA Dermatol; 2019 Jun; 155(6):700-707. PubMed ID: 30916734
[TBL] [Abstract][Full Text] [Related]
37. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.
Valaiyaduppu Subas S; Mishra V; Busa V; Antony I; Marudhai S; Patel M; Cancarevic I
Cureus; 2020 Oct; 12(10):e11173. PubMed ID: 33262910
[TBL] [Abstract][Full Text] [Related]
39. Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease.
Gustafson AC; Gelfand JM; Davies J; Lieberman AE; Mason JB; Armstrong AW; Ogdie A; Mehta NN; Barbieri JS; Beidas RS
J Psoriasis Psoriatic Arthritis; 2022 Oct; 7(4):174-186. PubMed ID: 38148879
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
